Primary analysis of the Endrad Trial: Non-Total Body Irradiation (TBI) Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) in Next-Generation-Sequencing Minimal Residual Disease (NGS-MRD) Negative B-Acute Lymphoblastic Leukemia (B-ALL) of Children, Adolescents, and Young Adults (CAYA) with High-Risk/Relapsed B-ALL with Planned Comparisons to the Observational Cohort (Pediatric Transplantation and Cellular Therapy Consortium ONC1701)

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Hisham Abdel‐Azim, Troy C. Quigg, Neena Kapoor, Yueh-Yun Chi, Anahit Baregamyan, Christine S. Higham, Leslie Lehmann, Amy K. Keating, Vanessa A. Fabrizio, Jodi L. Skiles, Shalini S. Shenoy, Jordan Milner
+15 more Rachel Phelan, Emi Caywood, Ulrich A. Duffner, Jonathan D. Fish, Jorge Galvez, Alfred Gillio, Rabi Hanna, Jeffrey S. Huo, Nahal Rose Lalefar, Kris Michael Mahadeo, Kevin Owen McNerney, Gregory Dolan, Dana B. Salzberg, Heather Emily Stefanski, Michael A. Pulsipher
DOI: 10.1016/j.jtct.2025.12.144
Cited by: 0

Fields of Study & Subjects

Acute Lymphoblastic Leukemia research Hematopoietic Stem Cell Transplantation Immunodeficiency and Autoimmune Disorders

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S98–S99
Publication date
1 February 2026
Language
EN